Browse studies

Find your next paid study

3,222 recruiting studies matching your filters

Prophylactic Lymphovenous Bypass Procedure Following Axillary Lymphadenectomy: A Prospective Observational Study

This pilot trial studies whether a procedure called lymphovenous bypass would prevent lymphedema (arm swelling) in patients with inflammatory breast cancer or …

Anatomic Stage III Breast Cancer AJCC v8Breast Inflammatory CarcinomaLocally Advanced Breast Carcinoma+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT03941756

Prospective Plasma Biomarker Study to Predict 2nd Line Endocrine Therapy Response in ER+ Metastatic Breast Cancer (TrackER)

This study looks at whether a simple blood test can help predict how well a breast cancer treatment will work. It follows patients with advanced hormone recept…

Breast Cancer (Advanced/Metastatic)ER Positive

Estimated

~$10 – $750

Actual pay is set by the research site.

University of PittsburghNCT07860866

Phase 2

CAMPFIRE: Children's and Young Adult Master Protocol for Innovative Pediatric Research

The main purpose of the master is to help the research sites and sponsor carry out several clinical trials more efficiently by providing a common research prot…

NeoplasmsChildAdolescent

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Eli Lilly and CompanyNCT05999994

Phase 1

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

A Phase 1/1B Study of ST-01156 in Patients with Advanced Solid Malignancies

Advanced Solid TumorsEwing SarcomaHepatocellular Carcinoma (HCC)+1 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

SEED Therapeutics, Inc.NCT07197554

Phase 1

Stereotactic Treatment With neoAdjuvant Radiotherapy and Enfortumab Vedotin: a Phase I/II Study With Safety Lead-In for Localized Bladder Cancer (STAR-EV)

STAR-EV will evaluate the combination of enfortumab vedotin plus radiotherapy (RT) as neoadjuvant treatment for bladder cancer prior to radical cystectomy surg…

Bladder Cancer

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of Texas Southwestern Medical CenterNCT06394570

Leveraging Behavioral Economics to Understand and Improve Financial Decision Making Among Vulnerable Older Adults

This study seeks to: * Identify behavioral preference patterns that characterize older adults vulnerable to financial exploitation. * Estimate the extent to w…

Financial Exploitation of Older Adults

Estimated

~$10 – $750

Actual pay is set by the research site.

The University of Texas Health Science Center, HoustonNCT07682727

Phase 1

A Phase 1a/1b, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Evidence of Antitumor Activity of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

Phase 1, open-label dose-escalation study to determine the MTD of INV-1120 and RP2D, and to assess the DLT of INV-1120 as a single agent or in the combination …

CancerSolid Tumor, AdultCancer Metastatic+3 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Shenzhen Ionova Life Sciences Co., Ltd.NCT04443088

Phase 1

A Phase I/II Open-Label, Dose Escalation, Dose Optimization, and Cohort Expansion Trial to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of UI-102, a Novel Cholesteryl Pullulan (CHP) Nanoparticle-formulated TLR7/8 Agonist in Patients With Selected Locally Advanced and/or Metastatic Solid Tumors

This phase 1/2 first-in-human study is designed to assess the safety and efficacy of UI-102, a TLR7/8 agonist encapsulated in a Cholesteryl Pullulan Nanopartic…

Advanced Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

United Immunity, co., Ltd.NCT07605962

Phase 2

A Phase 2 Randomized, Multicenter Study of Non-Invasive Vagus Nerve Stimulation (nVNS), Cannabidiol, and Standard of Care for the Treatment of Persistent Post-Traumatic Headache in Elite Athletes

Do cannabidiol (CBD) or vagus nerve stimulation reduce the frequency of persistent post-traumatic headache more than traditional oral headache medications?

Persistent Post Traumatic Headache

Estimated

~$75 – $2,800

Actual pay is set by the research site.

American Society of Pain and Neuroscience, Inc.NCT07624279

Observational

Expiratory Muscle Strength Training as a Non-surgical Option for Velopharyngeal Dysfunction: A Randomized-controlled Trial

When the soft palate does not move enough because of a cleft palate or for unknown reasons, this can lead to a speech difference called velopharyngeal insuffic…

Velopharyngeal InsufficiencyVelopharyngeal Incompetence Due to Cleft PalateInadequate Velopharyngeal Closure+2 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Noel JabbourNCT05492266

Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD

This study is for people who have had a lung transplant and developed a condition called chronic lung allograft dysfunction (CLAD), which is a type of chronic …

Lung Transplant Failure and RejectionCLAD, Bronchiolitis ObliteransExtracorporeal Photopheresis

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Brian KellerNCT07434869

Phase 1

A Phase 1/1b Open-label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of KIN-2787 in Participants With BRAF and/or NRAS Mutation-positive Solid Tumors.

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of KIN-2787 in adults with BRAF/NRAS-mutated…

Solid Tumor, AdultNon-small Cell Lung CancerMelanoma

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Pierre Fabre MedicamentNCT04913285